News Conference News AHA 2017 Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery Shelley Wood November 14, 2017
News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Daily News Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events Todd Neale September 25, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Industry News New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes September 15, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Daily News ‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low Michael O'Riordan August 01, 2017
News Conference News ACC 2017 SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab Yael L. Maxwell March 17, 2017
News Conference News ACC 2017 Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions Shelley Wood March 09, 2017
News Conference News ISC 2017 Ticagrelor May Be Useful After Stroke, TIA if Event Related to Atherosclerosis Todd Neale February 28, 2017
News Conference News ISC 2017 Big Fluctuations in Blood Pressure Signal a Higher Stroke Risk in Well-Controlled Hypertensives Todd Neale February 24, 2017
News Daily News How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows Yael L. Maxwell January 31, 2017